- Home
- WKEY vs HLVX Comparison
WKEY vs HLVX Comparison
Compare WKEY & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- HLVX
- Stock Information
- Founded
- WKEY 1999
- HLVX 2020
- Country
- WKEY Switzerland
- HLVX United States
- Employees
- WKEY N/A
- HLVX N/A
- Industry
- WKEY EDP Services
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- HLVX Health Care
- Exchange
- WKEY Nasdaq
- HLVX Nasdaq
- Market Cap
- WKEY 86.9M
- HLVX 83.7M
- IPO Year
- WKEY N/A
- HLVX 2022
- Fundamental
- Price
- WKEY $6.70
- HLVX $2.06
- Analyst Decision
- WKEY Strong Buy
- HLVX Hold
- Analyst Count
- WKEY 1
- HLVX 5
- Target Price
- WKEY $4.00
- HLVX $2.33
- AVG Volume (30 Days)
- WKEY 251.7K
- HLVX 454.3K
- Earning Date
- WKEY 07-15-2025
- HLVX 08-07-2025
- Dividend Yield
- WKEY N/A
- HLVX N/A
- EPS Growth
- WKEY N/A
- HLVX N/A
- EPS
- WKEY N/A
- HLVX N/A
- Revenue
- WKEY $11,875,000.00
- HLVX N/A
- Revenue This Year
- WKEY $18.18
- HLVX N/A
- Revenue Next Year
- WKEY $112.51
- HLVX N/A
- P/E Ratio
- WKEY N/A
- HLVX N/A
- Revenue Growth
- WKEY N/A
- HLVX N/A
- 52 Week Low
- WKEY $1.61
- HLVX $1.34
- 52 Week High
- WKEY $14.00
- HLVX $14.43
- Technical
- Relative Strength Index (RSI)
- WKEY 53.41
- HLVX 63.20
- Support Level
- WKEY $6.21
- HLVX $1.99
- Resistance Level
- WKEY $7.12
- HLVX $2.12
- Average True Range (ATR)
- WKEY 0.57
- HLVX 0.08
- MACD
- WKEY -0.04
- HLVX 0.02
- Stochastic Oscillator
- WKEY 75.82
- HLVX 80.33
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.